FDA approves J&J's autoimmune drug Stelara for Crohn's disease
September 26, 2016 at 10:06 AM EDT
Sept 26 (Reuters) - Johnson & Johnson said on Monday that the U.S. Food and Drug Administration approved the company's blockbuster psoriasis drug, Stelara, for use in adults with Crohn's disease.
